Mingxu Wu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Mingxu Wu has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Ting Zhang
Institute of Herbgenomics, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China
2 shared publications - Xiaojuan Tian
Institute of Herbgenomics, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China
2 shared publications - Anqiang Jia
Institute of Herbgenomics, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China
1 shared publication - Lingping Yang
Institute of Herbgenomics, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China
1 shared publication - Liying Feng
Yazhouwan National Laboratory, Sanya, China
1 shared publication - Mingming Liu
School of Basic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China
1 shared publication
Latest Publications
- Open Access
Subgenome-Resolved Analysis and Regulatory Divergence of UDP-Glycosyltransferases in Allotetraploid Panax ginseng
Background: Polyploidization generates extensive gene redundancy, but how duplicated metabolic genes are retained and subsequently diversified remains poorly understood. UDP-glycosyltransferases (UGTs) provide a suitable system for examining this process because they participate in specialized metabolism, plant development, and environmental responses. This study aimed to characterize the retention, expansion, and regulatory divergence of the UGT family in allotetraploid Panax ginseng at subgenome resolution. Methods: We integrated telomere-to-telomere (T2T) genome annotation, phylogenetic and chromosomal analyses, duplication classification, collinearity and Ka/Ks analyses, promoter cis-acting element prediction, developmental co-expression networks, and transcriptomic responses to biotic and abiotic treatments. Results: A total of 212 PgUGT genes were identified, including 104 and 108 members in the A and B subgenomes, respectively. The family exhibited an overall near-mirrored retention pattern between the two subgenomes, accompanied by local copy-number asymmetry. Whole-genome and segmental duplication accounted for 64.2% of the family, and 99.5% of the gene pairs with valid Ka/Ks estimates had values below 1, suggesting pervasive purifying selection. PgUGT-containing co-expression modules were associated with bud, stem, leaf, and fruit developmental conditions, while promoter cis-acting element compositions exhibited member-specific variation. Transcriptional responses to fungal pathogens and abiotic, hormone, and chemical treatments were concentrated in particular members and local gene arrays rather than being coordinated across entire clades or subgenomes. Conclusions: The PgUGT family is characterized by extensive ancestral copy retention accompanied by local copy-number changes and copy-specific regulatory divergence. These findings provide a subgenome-resolved framework for understanding UGT family evolution in allotetraploid ginseng and prioritize candidate PgUGT genes for subsequent functional validation.
Open AccessSubgenome-Resolved Analysis and Regulatory Divergence of UDP-Glycosyltransferases in Allotetraploid Panax ginseng
Background: Polyploidization generates extensive gene redundancy, but how duplicated metabolic genes are retained and subsequently diversified remains poorly understood. UDP-glycosyltransferases (UGTs) provide a suitable system for examining this process because they participate in specialized metabolism, plant development, and environmental responses. This study aimed to characterize the retention, expansion, and regulatory divergence of the UGT family in allotetraploid Panax ginseng at subgenome resolution. Methods: We integrated telomere-to-telomere (T2T) genome annotation, phylogenetic and chromosomal analyses, duplication classification, collinearity and Ka/Ks analyses, promoter cis-acting element prediction, developmental co-expression networks, and transcriptomic responses to biotic and abiotic treatments. Results: A total of 212 PgUGT genes were identified, including 104 and 108 members in the A and B subgenomes, respectively. The family exhibited an overall near-mirrored retention pattern between the two subgenomes, accompanied by local copy-number asymmetry. Whole-genome and segmental duplication accounted for 64.2% of the family, and 99.5% of the gene pairs with valid Ka/Ks estimates had values below 1, suggesting pervasive purifying selection. PgUGT-containing co-expression modules were associated with bud, stem, leaf, and fruit developmental conditions, while promoter cis-acting element compositions exhibited member-specific variation. Transcriptional responses to fungal pathogens and abiotic, hormone, and chemical treatments were concentrated in particular members and local gene arrays rather than being coordinated across entire clades or subgenomes. Conclusions: The PgUGT family is characterized by extensive ancestral copy retention accompanied by local copy-number changes and copy-specific regulatory divergence. These findings provide a subgenome-resolved framework for understanding UGT family evolution in allotetraploid ginseng and prioritize candidate PgUGT genes for subsequent functional validation.
- Open Access
- 23 March 2026
- Published by MDPI AG in Pharmaceuticals
- Vol. 19 (3) , 520
Danggui Buxue Decoction and Its Active Constituents Inhibit Drug-Induced Uterine Contractions via L-Type Calcium Channels and the IP3/Ca2+ Pathway
Background/Objectives: Primary dysmenorrhea is a common gynecological disorder characterized by painful uterine contractions. Danggui Buxue Decoction (DBD) is used to treat menstrual irregularities, but its mechanism in primary dysmenorrhea remains unclear. This study investigated the efficacy of DBD against dysmenorrhea and its calcium signaling-related mechanism. Methods: DBD components were analyzed by UPLC–Orbitrap MS. Isolated uterine muscle strips precontracted with oxytocin (OT, 50 ng/mL) or KCl (60 mM) were used to assess the effects of DBD and its active compounds (Quercetin, Formononetin, Ononin, Ferulic acid, Senkyunolide I, Calycosin, Ligustilide, Calycosin-7-O-β-D-glucoside). Ca2+-dependent experiments, intracellular calcium release assays, and inhibitor treatments (Nifedipine, 2-APB) were performed to evaluate the involvement of L-type calcium channels and the IP3R pathway. A primary dysmenorrhea model induced by estradiol benzoate and oxytocin was used to assess the analgesic effects, histopathology, inflammatory factors, and IP3/Ca2+-related proteins and genes following DBD and Quercetin treatment. Results: A total of 161 compounds were identified in DBD. DBD and its eight active constituents relaxed OT (50 ng/mL) or KCl (60 mM)-induced uterine contractions, with Quercetin, Calycosin, and Ligustilide showing particularly prominent relaxant activity. These three compounds suppressed extracellular calcium influx and intracellular calcium release through the blockade of L-type calcium channels and IP3R. In vivo, DBD and Quercetin alleviated pain, reduced inflammation, and decreased uterine Ca2+ and IP3 levels in dysmenorrhea mice. Conclusions: DBD and its active component Quercetin promote uterine relaxation by lowering Ca2+ levels, which is achieved through suppression of L-type calcium channels and the IP3/Ca2+ pathway. This contributes to their therapeutic action against primary dysmenorrhea.
- 23 March 2026
- Published by MDPI AG in Pharmaceuticals
- Vol. 19 (3) , 520
Open AccessDanggui Buxue Decoction and Its Active Constituents Inhibit Drug-Induced Uterine Contractions via L-Type Calcium Channels and the IP3/Ca2+ Pathway
Background/Objectives: Primary dysmenorrhea is a common gynecological disorder characterized by painful uterine contractions. Danggui Buxue Decoction (DBD) is used to treat menstrual irregularities, but its mechanism in primary dysmenorrhea remains unclear. This study investigated the efficacy of DBD against dysmenorrhea and its calcium signaling-related mechanism. Methods: DBD components were analyzed by UPLC–Orbitrap MS. Isolated uterine muscle strips precontracted with oxytocin (OT, 50 ng/mL) or KCl (60 mM) were used to assess the effects of DBD and its active compounds (Quercetin, Formononetin, Ononin, Ferulic acid, Senkyunolide I, Calycosin, Ligustilide, Calycosin-7-O-β-D-glucoside). Ca2+-dependent experiments, intracellular calcium release assays, and inhibitor treatments (Nifedipine, 2-APB) were performed to evaluate the involvement of L-type calcium channels and the IP3R pathway. A primary dysmenorrhea model induced by estradiol benzoate and oxytocin was used to assess the analgesic effects, histopathology, inflammatory factors, and IP3/Ca2+-related proteins and genes following DBD and Quercetin treatment. Results: A total of 161 compounds were identified in DBD. DBD and its eight active constituents relaxed OT (50 ng/mL) or KCl (60 mM)-induced uterine contractions, with Quercetin, Calycosin, and Ligustilide showing particularly prominent relaxant activity. These three compounds suppressed extracellular calcium influx and intracellular calcium release through the blockade of L-type calcium channels and IP3R. In vivo, DBD and Quercetin alleviated pain, reduced inflammation, and decreased uterine Ca2+ and IP3 levels in dysmenorrhea mice. Conclusions: DBD and its active component Quercetin promote uterine relaxation by lowering Ca2+ levels, which is achieved through suppression of L-type calcium channels and the IP3/Ca2+ pathway. This contributes to their therapeutic action against primary dysmenorrhea.